Ftse Mib
33.031,05
-2,15%
DAX
18.952,05
-1,17%
S&P 500
5.893,62
0,39%
NASDAQ
18.791,81
0,60%
Bitcoin
91.724,55
1,30%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ReShape Lifesciences Inc (RSLS) ReShape Lifesciences Inc (RSLS) Notizie

ReShape Lifesciences Inc

RSLS
5,29
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:42:36
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/11/202422:31EDGAR2Form 8-K - Current report
14/11/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202422:05GLOBEReShape Lifesciences® Reports Third Quarter Ended September..
12/11/202422:05GLOBEReShape Lifesciences® to Announce Financial Results for the..
12/11/202414:31GLOBEReShape Lifesciences® Receives Health Canada Approval for..
11/11/202414:31GLOBEReShape Lifesciences® Receives NIH Supplementary Grant with..
17/10/202415:15EDGAR2Form 8-K - Current report
01/10/202423:22EDGAR2Form S-4 - Registration of securities, business combinations
26/9/202422:45EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
19/9/202414:31GLOBEReShape Lifesciences Announces 1-for-58 Reverse Stock Split
28/8/202422:03EDGAR2Form 425 - Prospectuses and communications, business..
28/8/202422:01EDGAR2Form 425 - Prospectuses and communications, business..
14/8/202422:45EDGAR2Form 8-K - Current report
14/8/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202422:05GLOBEReShape Lifesciences® Reports Second Quarter Ended June 30,..
13/8/202414:31GLOBEReShape Lifesciences® to Announce Financial Results for the..
09/7/202418:13GLOBEVyome to go public and trade on the Nasdaq Capital Market..
09/7/202415:22EDGAR2Form 425 - Prospectuses and communications, business..
09/7/202415:21EDGAR2Form 8-K - Current report
09/7/202414:31GLOBEReShape Lifesciences® Enters Into Merger Agreement With..
20/5/202423:14EDGAR2Form 8-K - Current report
15/5/202422:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202422:05GLOBEReShape Lifesciences® Reports First Quarter Ended March 31,..
14/5/202414:31GLOBEReShape Lifesciences® to Announce Financial Results for the..
01/4/202422:05GLOBEReShape Lifesciences® Reports Year Ended December 31, 2023..
28/3/202413:31GLOBEReShape Lifesciences® Receives Notice of Allowance for..
04/3/202414:31GLOBEReShape Lifesciences® Provides Update on 2024 Cost Reduction..
26/2/202422:19EDGAR2Form 8-K - Current report
22/2/202414:31GLOBEReShape Lifesciences® Announces First Surgeries Utilizing..
24/1/202414:31GLOBEReShape Lifesciences® Conducts Bariatric Fellows Training..
18/1/202422:38EDGAR2Form 8-K - Current report
17/1/202400:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/1/202422:14EDGAR2Form PRE 14A - Other preliminary proxy statements
20/12/202314:31GLOBEReShape Lifesciences® Engages Maxim Group LLC To Identify..
12/12/202322:05GLOBEReShape Lifesciences® Receives FDA PMA Supplement Approval..
29/11/202322:05EDGAR2Form 8-K - Current report
21/11/202314:06GLOBEReShape Lifesciences® Enters into Warrant Exercise..
Apertura: Min: Max:
Chiusura: 5,29

La tua Cronologia

NASDAQ
RSLS
ReShape Lifesciences
BIT
UB8VQS
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network